UPMC Ireland’s Post

A recent study sheds light on the significant role of #CHIP in increasing cardiovascular risk in patients with asymptomatic carotid atherosclerosis. The study, published in the Journal of the American College of Cardiology, reveals a direct correlation between #CHIP and cardiovascular events in these patients. Check out the study here: https://lnkd.in/g2J-uAYx #Atherosclerosis #cardiovascular #CHIP #clonalhematopoiesis

Excellent review of the hopes with the next CETPi - OBICETRAPIB - Open access at https://lnkd.in/eb3npS8D National Lipid Association European Atherosclerosis Society European Society of Cardiology

Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan - Diagnostic and Interventional Cardiology: Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan  Diagnostic and Interventional Cardiology http://dlvr.it/T5xXWp #ai #artificialintelligence

Excited to share our review article entitled "Cardiac Autonomic Plexus Neuromodulation for Decompensated Heart Failure: An Updated Review on the Positive Ionotropic Technique based on the DRIPS Classification" is now published in Current Problems in Cardiology. In our Review Article, we comprehensively discussed Pathophysiology of Acute Decompensated Heart Failure (ADHF) in relation to modern neuromodulation techniques such as the Cardiac Pulmonary Neurostimulation (CPNS). We used graphics to elaborate on the The multifactorial pathophysiology of ADHF and how past and present treatments are targetting a different aspect of that pathophysiology. We discussed results from trials like NECTAR, ANTHEM-HF, and INNOVATE-HF and shed light on the ongoing STIM-ADHF & STOP-ADHF trials. I highly encourage all aspiring cardiologists to read our review article for in-depth understanding of such developing treatment options. Access the article using the link below: https://lnkd.in/eqUdTkX7 American College of Cardiology Eeshal Fatima Zain Nadeem Research Council of Pakistan

Bridge Bio Eidosibute ( AG10) in phase III for ATTRcm is a new opction for ouers Amilos whith transtirretin. #Acoramidis #ATTRCM #PhaseIII #SOMOSAMILO www.amilo.es

Thrilled to share another abstract we have published in the Journal of the American College of Cardiology : Efficacy and Safety of Mavacamten for the Treatment of Hypertrophic Cardiomyopathy: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Took a break from research because of my final exams nowadays, but l will be back. You can read our recent abstract presented in Euro PCR 2024 in Interventional Cardiology entitled with "Ultrathin vs. Standard Strut Drug-Eluting Stent: A 5-Year Meta-Analysis of Clinical outcomes" in this link https://lnkd.in/d2y_-S6X

An illustration of mine showing the lipolytic complexities of TG-containing VLDL-apoB particles in a 2018 manuscript. https://lnkd.in/er3AFwyp National Lipid Association European Atherosclerosis Society European Society of Cardiology

Thank you to the organizers of the third international webinar on cardiology for the opportunity to present my research. I am grateful for the chance to share my insights on such an important topic. The video recording of my presentation is now available on their YouTube channel, and I invite you to watch and share it to help spread knowledge in the field of cardiology. Together, we can make a difference in advancing cardiovascular health. #Cardiology #Research #KnowledgeSharing" https://lnkd.in/eiAEFkQ5

More contemporary ATTRibute-CM data elevating our understanding of ATTR-CM to be presented at #ESCHeartFailure in #Lisbon, #Portugal by global amyloidosis experts and colleagues, #SteenPoulsen, #PabloGarciaPavia, #MariannaFontana, #PeterVanDerMeer, and #LauraObici